A novel classification for IgA nephropathy

Kidney International

Volumn 76, Issue 5, 2009, Pages 477-480

  Yamamoto, Ryohei ^a   Imai, Enyu ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; IMMUNOSUPPRESSIVE AGENT;

ADULT; BLOOD PRESSURE; CASE REPORT; COHORT ANALYSIS; CONSENSUS; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; DISEASE COURSE; GLOMERULONEPHRITIS; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; LUPUS ERYTHEMATOSUS NEPHRITIS; NOTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY; RISK FACTOR;

EID: 68949209104     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.206     Document Type: Note

References (9)

1. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int 2001; 60: 1998-2012 .
2. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
3. Furness PN, Taub N. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis: a UK-wide study. Am J Surg Pathol 2006; 30: 1030-1035.
4. Grootscholten C, Bajema IM, Florquin S et al. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant 2008; 23: 223-230.
5. Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H.S. Lee's glomerular grading system. Nephrol Dial Transplant 2005; 20: 342-348.
6. Katafuchi R, Kiyoshi Y, Oh Y et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998; 49: 1-8.
7. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: Cattran D, Coppo R, Cook T et al. The Oxford Classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545.
8. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: Roberts ISD, Cook HT, Troyanov S et al. The Oxford Classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556.
9. Katafuchi R, Ikeda K, Mizumasa T et al. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy. Am J Kidney Dis 2003; 41: 972-983.